chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I started with a sore throat that night. I tested the next day morning and it was negative. On the 14th I tested positive. The sore throat was really the only symptom I experience. I spoke to my Doctor and was given Paxlovid and took it and had no other symptoms.
This case was considered medically important (OMIC). Information regarding HIB-TITER was received from an attorney regarding a male patient who received a dose on an unspecified date and experienced mercury poisoning and permanent neurological damage. Relevant medical history was not provided. Indication for HIB-TITER vaccine was immunization. Product was administered on an unspecified date. Dose regimen was not provided. Additional suspect medication included administration of four DPT injections. Concomitant medications were not reported. It is alleged that as a result of a cumulative exposure to mercury in the thimerosal-containing vaccine, the child suffers from mercury poisoning and permanent neurological damage. The reporter indicated the child received a dose of HIB-TITER on an unspecified date. The patient also received four doses of DPT prior to October 1986. The reporter indicated that the patient first manifested regression of neurological abilities in August and September of 1986. Per the reporter, the child was subsequently diagnosed by a medical doctor with neurological impairment in June of 1987. No additional information was available at the time of this report.
Admitted to hospital; test covid positive; supplemental oxygen; dexamethasone; remdesivir
Information has been received from a registered nurse concerning a female who was vaccinated with GARDASIL. It was reported that the patient had received one dose of GARDASIL and experienced dizziness. It was not reported, if she was one of the patient's that had not eaten that day prior to her vaccination or if she was one of the patients that had received another vaccine at the same time. The patient was observed at the office for an unspecified period and then was allowed to leave. It was reported that the patient recovered. This is one of two patients. Attempts are being made to obtain additional identifying information to distinguished the individual patients mentioned in this report. Additional information will be provided if available. Additional information has been requested. 10/08/07 This is in follow-up to report(s) previously submitted on 7/6/2007. In follow-up it was reported by the registered nurse that she did not know the patient that was described and she couldn't look up the lot number or give anymore information. Additional information has been requested.
Fever, chills, headaches starting 12 hours after injection. The symptoms persisted for 24 hours, both times of injections. Pain in my right ovary causing me to start my period before my scheduled day both shots.
Hand tingled in the right arm that the vaccine was put in in under 5 minutes of getting it.; The next day, just my arm hurt; Within 20/25 minutes of waking up I began having a light chest pain; chills; cold; body aches; Head hurt; Very tired; This is a spontaneous report from a contactable consumer or other Non-health care professional. A 35-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: EL9267), via an unspecified route of administration, in right arm (at the age of 35-year-old) on 11Feb2021 14:00 as dose 1, single for covid-19 immunization. Medical history included covid-19 from an unknown date and unknown if ongoing and was reported as none. The patient's concomitant medications were not reported. Patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications in two weeks prior to the vaccination. On 11Feb2021 14:15 the patient experienced hand tingled in the right arm that the vaccine was put in in under 5 minutes of getting it. Then, whole arm was tingling and later the whole arm hurt and tingled. Later that evening it was very cold. On the next day, just her arm hurt, and she felt great. Within 20/25 minutes of waking up she began having a light chest pain. It lingered all day. Later began with chills, cold and body aches. Just got worse throughout the day. Head hurt off and on all day for a few seconds and then would go away. Very tired. Arm hurt bad. The patient did not receive treatment. The outcome of events was recovered on an unspecified date in 2021.  Follow-up attempts completed. No further information expected.
Muscle atrophy; This spontaneous case was reported by a pharmacist and describes the occurrence of MUSCLE ATROPHY (Muscle atrophy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE ATROPHY (Muscle atrophy). At the time of the report, MUSCLE ATROPHY (Muscle atrophy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported.     No treatment medications were reported.
Red rash in the right arm which was the vaccination site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Red rash in the right arm which was the vaccination site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced VACCINATION SITE RASH (Red rash in the right arm which was the vaccination site). At the time of the report, VACCINATION SITE RASH (Red rash in the right arm which was the vaccination site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
pt recv vax & exp lump @ inj site which was described as a thick & knotty & lasted for a couple of months;
Redness at injection site, 3" long inside and lighter red 5" oval. Redness subsiding so no treatment used.
Sore knot under left breast and sinus infection. Dr prescribed antibiotic, zpack, to help with both. Size of knot under breast was reduced and soreness went away. After I finished antibiotics, mouth got sore. Left side of tongue and inside top lip. I am taking Benadryl, benzocaine lozenges, and  Ambesol right now (started 1/7/2023).
3-month-old was given a flu shot too early.  Called father to inform and he said patient is doing well and has no complaints. They will reschedule for 6-month-old shots.
24 hours post Pneumococcal Vaccination, patient developed pain and swelling at injection site. Area was 16 cm x 12 cm and warm to the touch. Warm packs applied x 24 hours.
DIAGNOSED WITH CIDP/GUILLIAN BARRE SYNDROME IN MAY 2003 HE RECEIVED THE MENINGITS  VACCINE IN NOVEMBER 2002. Confirmed with parent and vax record concurs Flu vaccine given 12/8/2003, not meningococcal. Onset of sx January 2004, not 2003 as originally reported. 7/14/2008 Death Cert received with Immediate COD listed as Chronic Inflammatory Demyelinating Polyneuropathy. 06/03/2008 MR received for DOS 1/23-28/2008 with D/C DX:  Neuropathy. 2' DX:  Tachycardia.  Respiratory Distress. Pt most recently presented to another facility in December 2007 with GI issues and increasing lower extremity weakness. Pt was discharged and was transferred for further evaluation due to progressive upper extremity weakness and dyspnea, as well as new onset urinary and fecal incontinence, orthostasis, decreased hearing and L hand pain. Pt had initially developed limb weakness and paresthesias 4 years ago. Testing showed widespread sensory motor polyneuropathy. DX: Presumed Chronic Inflammatory Demyelinating Polyneuropathy. Course has been slowly progressing over the years and has had multiple hospitalizations and rehabs. PE (+) for tachycardia, use of accessory muscles for breathing, tachypnea and decreased breath sounds. Bowel sounds decreased. Motor exam showed decreased bulk, tone and strength. Sensation decreased with no proprioception below the elbow. Pt txd with plasmapheresis IVIG over the years without response. Pt now with autonomic dysfunction. BIPAP improved overall energy level. Pt unable to return to rehab facility given questionable prognosis so pt was D/C to home. Per mother pt died at home on 2/17/2008. PMH since 2003: (CIDP dx 2004 with depression, anxiety, osteoporosis.  Sural nerve bx, OSA on CPAP, Recent Gastroenteritis.)
Patient came back to pharmacy to get her antibiotic filled for the cellulitis and showed me the reaction site and said dr diagnosed her with cellulitis/infection on the arm pneumovax was administered.
Information has been received from a registered nurse (RN) concerning a 16  week old patient who on 09-MAR-2007, was vaccinated with the first dose of rotavirus vaccine (human-bovine) (Lot # 654392/0578F). No symptoms have been reported. Additional information has been requested.
Metal Mouth within 15 minutes; 5 hours later sever chills and violent shakes for the next 8 hours; resting heart rate between 96 to 100 bpm (my average resting heart rate if 65-68 bpm) until 18 hours after receiving the shot; no sleep the first night after the shot; intense headache that over the counter medicine could not help nor did meditation; my body was shaking so hard it threw out my hip and muscles in my back spasmed; hard to walk; joint pain in back, arms, and legs; fever up to 102; the following 24 hours after the first day felt like I had COVID with a cold, sinus headache, exhaustion, and body aches. Second night difficult sleeping as well.
pt recvd vax 330PM mom gave APAP as directed p/clinic visit, 10PM pt crying t102 mom took pt to ER; temp reported @ ER 100; ER also reports high pitched cry which mom states is nl for the pt; red, lump on rt leg; APAP, DPH given;
Patient received the flu shot in the right arm am 11-19-16. She returned the next morning (11-20-16) complaining of right shoulder soreness/pain. She also states pain/numbness in shoulder, under pit area and chest.
On October 22, 2008 I got the Influenza Vaccine at approximately 10:30 am. Around 1:30 I started feeling dizzy and cloudy. By 3:00 pm I was feeling sore and shaky and around 4 pm I started getting very cold. I was freezing and no matter how many blankets I wrapped around myself I was still cold. My temperature spiked to 103.7 and I was still freezing and unable to move. I couldn't breath and my tongue felt odd.  By 6:30 I was unable to walk at all, my husband threw me in a cold shower and brought my temperature down at which time I took allergy pills and Tylenol and my temperature fell down to 99.9, but it kept spiking up to 101 to 103 for another 30-45 minutes at which point my temperature stabilized and I was able to move around again. I believe it was an allergic reaction as the next day I was completely fine.
have a fever; whole body hurts; feel like throwing up; This spontaneous case was reported by a pharmacist and describes the occurrence of PYREXIA (have a fever), MYALGIA (whole body hurts) and NAUSEA (feel like throwing up) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2022, the patient experienced PYREXIA (have a fever), MYALGIA (whole body hurts) and NAUSEA (feel like throwing up). At the time of the report, PYREXIA (have a fever), MYALGIA (whole body hurts) and NAUSEA (feel like throwing up) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No any concomitant medications were reported. No any treatment medications were reported.
Large red hard knot appeared.  Area is 2 inches by 2.5 inches.   Swelling is increasing and site is warm to the touch.   Somewhat painful, but tolerable.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 12-APR-2016, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot # L012521, expiration date: 01-FEB-2017) (dose and route of administration were not reported). There was no adverse events reported. This is one of several reports received from the same reporter. Additional information has been requested.
DIED; This spontaneous report received from a consumer via a company representative concerned a 43 year old male of unspecified race and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry date were not reported) dose, start therapy date were not reported, 1 in total was administered for covid-19 prophylaxis. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. Age at time of vaccination 5 decade old. No concomitant medications were reported.  On an unspecified date, 16 days later after vaccination the patient died from unknown cause of death. It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20231126772-Died. Insufficient information is available to make a causality assessment. Therefore, this event is considered unclassifiable.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
HIGH BLOOD PRESSURE; CHEST TIGHTNESS; DIZZINESS; STAGGERING FROM WALKING; This spontaneous report received from a patient concerned 61 year old female patient.  The patient's weight was 183 pounds, and height was 167.64 centimeters. The patient's concurrent conditions included high blood pressure, COPD (Chronic Obstructive Pulmonary Disease), thyroid problem, severe arthritis, non-alcoholic user, non-smoker, allergic to ginger (throat closes), drug allergy to sulfur, drug allergy to antihistamines and steroid rash. The patient did not had drug abuse or illicit drug usage. The patient was not pregnant at the time of reporting.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, expiry: UNKNOWN) dose was not reported, administered on 12-MAR-2021 in the left arm for prophylactic vaccination. The patient's concomitant medications included two unspecified BP (blood pressure) medications.  On 12-MAR-2021, the patient received covid-19 vaccine and she experienced high blood pressure (180/120 mm hg), her chest got tight, she was dizzy and had staggering from walking. On 12-MAR-2021, the patient took BP medicine directly after receiving vaccine to get BP down. Laboratory data included: Blood pressure (NR: not provided) 180/120 mmHg. On 13-MAR-2021, Laboratory data included: Blood pressure (NR: not provided) 152/106 mmHg. On 22-MAR-2021, her BP was still elevated and her other symptoms had resolved.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable.  The patient recovered from chest tightness, dizziness, and staggering from walking, and had not recovered from high blood pressure. This report was serious (Other Medically Important Condition).  Additional information received from consumer on 22-MAR-2021.The following information was updated and incorporated into the case narrative: patient demographics (age, weight, height), concurrent conditions (drug allergy to sulfur and antihistamine and steroid rash) event outcome updated (recovered/ resolved for events chest tightness, dizziness and staggering from walking).; Sender's Comments: V1: The follow up information in this version updates patient demographics, concurrent conditions (drug allergy to sulfur and antihistamine and steroid rash) event outcome updated (recovered/ resolved for events chest tightness, dizziness and staggering from walking) and narrative updated. This updated information does not alter the prior causality assessment for the reported event 20210325494- Covid-19 Vaccine Ad26.Cov2.S - Blood pressure high. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: MEDICAL HISTORY.
getting red below the injection site/ was redder; felt like it was getting pinched; itching and getting red below the injection site; warm to the touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE PRURITUS (itching and getting red below the injection site), VACCINATION SITE ERYTHEMA (getting red below the injection site/ was redder) and VACCINATION SITE PAIN (felt like it was getting pinched) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE WARMTH (warm to the touch). On 29-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itching and getting red below the injection site). On 30-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (getting red below the injection site/ was redder) and VACCINATION SITE PAIN (felt like it was getting pinched). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE PRURITUS (itching and getting red below the injection site), VACCINATION SITE ERYTHEMA (getting red below the injection site/ was redder) and VACCINATION SITE PAIN (felt like it was getting pinched) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Guest experienced a syncopal episode post vaccination and then developed nausea.  Guest reports all symptoms resolved and refused further medical evalaution.
Left leg (thigh) started swelling early Tuesday. Swollen area progressively got larger and "tighter". Two areas about the size of a quarter each. (Vescular rash) noted over top of thigh. No elevated temperature. Very painful to touch.
Excruciating armpit/breast lymph node pain; Aches; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Apr2021 at 11:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included Hashimoto's thyroiditis, Gastroesophageal Reflux Disease (GERD), anemia, depression and anxiety. The patient was allergic to sulfa and quinolone. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included pantoprazole sodium sesquihydrate (PROTONIX), levothyroxine sodium (SYNTHROID), bupropion hydrochloride (WELLBUTRIN), escitalopram oxalate (LEXAPRO), vitamin D nos (MANUFACTURER UNKNOWN) and fluticasone propionate (FLONASE); all taken for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Apr2021 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. On 26Apr2021 at 03:30, about 40 hours after the vaccination, the patient experienced excruciating armpit/breast lymph node pain with aches and sore arm. The node pain did not respond to Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with NSAIDs (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events aches and sore arm was recovered on an unknown date in Apr2021 while armpit/breast lymph node pain was not recovered at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
After waiting for 30 minutes post-injection, started to drive home and started burping repeatedly and incessantly.  Still burping over 3 hours later.  Mild itching on inside wrist of injection arm and neck.  No other symptoms so far.  Drove back to vaccine hub and waited with a nurse for observation and they sent me home with advice of going to urgent care/er/doctor if or as necessary.
Pt had a runny nose, sinus congestion, mild cough, aches and fatigue after school on 9/15/21. She was tested for Covid (rapid and PCR) on 9/16 and tested positive on both. She was quarantined at home until 9/25/21. Coughing stopped after 3-4 days.  On 9/23 she began coughing again. On 9/24, she began nebulizer treatments every 3-4 hours to control her coughing and wheezing symptoms. On 9/26 we went to urgent care because her wheezing and coughing were not improving despite continued nebulizer treatments. She received a chest x-ray, which was negative for pneumonia. Dr. prescribed a 5-day, tapering dose of Prednisone, beginning with 40 mg.
Pt vaccinated with Immovax developed extreme local redness at site of injection generalized rash within 25 min. of administration.
Information has been received from a certified medical assistant concerning a female patient between the age of 15 to 18 who was vaccinated with a dose of HPV rL1 6 11 16 18 VLP vaccine (yeast) (lot # 658556/1060U). Subsequently, the patient complained of stinging. It was noted that the stinging was only for a moment and resolved quickly. The reporter felt that the stinging could be from the vaccine being cold.Approximately 10 minutes post vaccination, the patient got pale, lightheaded and passed out. Unspecified medical attention was sought. It was reported that the patient rested and a neurological check was performed. No product quality complaint was involved. Additional information has been requested.
pt has had history of fainting for vaccines, as it was noted on  VAR. Pt got vaccine, got dizzy, and passed out.. he woke back up, was responsive and was able to answer all of our questions. we had him stay still, as to not get dizzy again.
It was reported that a 44 year old male received a Fluzone SV '99-'00 vaccination on 10/8/99. Reportedly, 12 hours, post vax, the pt developed myalgia. From additional correspondence received on 11/22/99, it was reported that the pt developed myalgia in his fingers of the extremity in which the vaccine was placed. Myalgia resolved in about 24 hours. No treatment was required.
Within one day of receiving vaccine, patient had itchy welts on groin, abdomen, inner thigh, behind knees. This increased in number on day two . (I am reporting on day 2.)